Delivery Order SPE2DB22D3004-SPE2DB24FNN77
Award Date 11/28/23
Potential Completion Date 11/29/23
Potential Value $5.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUQL9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,061.04 firm fixed-price delivery order is for the supply of 4567021473 MEDROXYPROGESTERONE 150 MG/ML. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,547.51 firm-fixed-price delivery order is for the supply of 4557973807 units of 150 mg/mL medroxyprogesterone, with an ultimate completion date of August 3, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This federal contract award, valued at $3,189.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566188922 - MEDROXYPROGESTERONE 150 MG/ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 24, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,772.99 fixed-price delivery order contract is for the supply of Medroxyprogesterone, a pharmaceutical drug. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Medroxyprogesterone 150 mg/mL. The Firm Fixed Price delivery order, valued at $1,504.84, was awarded on February 7, 2022 with a completion date of February 8, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price valued at $1,717.80. The contract is for the provision of medroxyprogesterone 150 mg/ml, a pharmaceutical product, to support military healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that maintains Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.41 contract is for the delivery of 4560862923 units of Medroxyprogesterone 150 mg/mL, a specialty medication. This is a firm fixed-price delivery order contract with a completion date of May 9, 2023. The contract is not set aside for any particular business type. Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,332.20 firm fixed-price contract is for the delivery of 4,568,260,604 milliliters of the drug medroxyprogesterone 150 mg/mL. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Medroxyprogesterone 150 mg/ml, a hormone treatment pharmaceutical, on November 14, 2025. This firm fixed-price delivery order, valued at $3,153.62, is scheduled for completion by November 17, 2025 and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating the contract was competitively awarded through open competition. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 150 mg/ml medroxyprogesterone injections. The contract has a ceiling value of $2,497.81 and a period of performance through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 and running through December 31,...